Getting Ozempic completely free is possible if you’re uninsured with a low income or on certain Medicare plans, through Novo Nordisk’s own patient assistance program. For everyone else, several programs can bring the cost down dramatically, sometimes to as little as $25 a month. The path that works for you depends on your insurance status, income, and diagnosis.
Novo Nordisk’s Patient Assistance Program
The manufacturer of Ozempic runs a program through NovoCare that provides the medication at no cost. To qualify in 2026, you need to fall into one of two categories: you either have no insurance at all, or you have Medicare without Part D drug coverage.
If you’re uninsured, your total household income must be at or below 200% of the federal poverty level. For a single person in 2025, that’s roughly $31,000 a year. Once approved, you’re enrolled for 12 months and receive Ozempic at zero cost for that entire period. You can reapply when the enrollment expires.
There’s an important limitation here. If you have private or commercial insurance of any kind, you don’t qualify for this program, even if your plan doesn’t cover Ozempic and you’re paying full price out of pocket. The program is specifically designed for people with no coverage or with Medicare gaps.
Medicare and Extra Help
Most Medicare Part D plans now cover Ozempic for type 2 diabetes, which means Medicare beneficiaries with Part D are no longer eligible for the free patient assistance program. But if your copays are still a burden, Medicare’s Extra Help program (also called the Low Income Subsidy) can cut costs significantly.
Under Extra Help in 2026, you pay no monthly plan premium and no deductible. Each brand-name prescription costs up to $12.65, and generics cost up to $5.10. Once your total drug costs for the year reach $2,100, you pay nothing for the rest of the year. If you also have full Medicaid coverage and are in the Qualified Medicare Beneficiary program, your copay drops to no more than $4.90 per prescription. That’s not technically free, but it’s close.
Medicaid Coverage
Medicaid is required to cover Ozempic when it’s prescribed for type 2 diabetes, since the drug’s FDA approval is for that condition. If you have Medicaid and a diabetes diagnosis, your out-of-pocket cost will typically be minimal or zero depending on your state.
Coverage gets more complicated if you’re looking at Ozempic for weight loss. Only 13 state Medicaid programs covered GLP-1 medications for obesity treatment under fee-for-service as of January 2026. Since Ozempic is not FDA-approved for obesity (that’s Wegovy, also made by Novo Nordisk), getting Medicaid to cover an off-label weight loss prescription is unlikely in most states.
Savings Cards for Commercial Insurance
If you have private or employer-sponsored insurance that covers Ozempic, the manufacturer’s savings card can bring your copay down to as little as $25 per month. The card provides up to $100 in monthly savings and is valid for up to 48 months. You activate it through the Ozempic website or NovoCare.
This won’t help if your insurance doesn’t cover Ozempic at all, since the savings card only reduces your share of a covered prescription. It also doesn’t apply to government insurance like Medicare, Medicaid, or Tricare.
Third-Party Foundation Grants
Organizations like the PAN Foundation offer grants that help cover medication costs for people with specific diagnoses. To qualify, you typically need health insurance that covers your medication (the grant helps with what insurance doesn’t pay), income below a threshold set by the specific disease fund, and U.S. residency. You must be currently in treatment, have received treatment within the last 90 days, or be scheduled to start within 120 days.
These foundations open and close their disease-specific funds based on available donations, so a diabetes fund might be open one month and closed the next. It’s worth checking periodically if you’re turned away the first time. The NeedyMeds and PAN Foundation websites both maintain searchable databases.
Getting Insurance to Cover It
Many commercial insurers require prior authorization before they’ll cover Ozempic. Understanding what they look for can help you and your doctor build a stronger case. Typical approval criteria include a type 2 diabetes diagnosis plus at least one of the following: you tried metformin and it didn’t work well enough or caused side effects, your A1C is 7.5% or higher and you need combination therapy, or you have established cardiovascular disease.
If you’re already on another GLP-1 medication and want to switch to Ozempic, insurers generally want to see that your A1C has improved since starting GLP-1 therapy. If your initial prior authorization is denied, your doctor can file an appeal with additional clinical documentation. Many denials are overturned on appeal, particularly when the prescriber can demonstrate that alternative medications were tried first.
Reduced Cash-Pay Prices
If you don’t qualify for free programs and don’t have insurance coverage, Novo Nordisk has lowered its direct-to-consumer cash price. The standard monthly cost through NovoCare’s direct purchasing channel is now $349 for most doses, down from $499. The highest dose of Ozempic still costs $499 per month.
New cash-paying patients may also find introductory offers. Novo Nordisk has periodically offered the two lowest doses at $199 per month for the first two months, after which the standard $349 price applies. These offers are available through the Ozempic website, NovoCare, and partner organizations including Costco, GoodRx, WeightWatchers, Ro, LifeMD, and eMed. These aren’t free, but for someone paying full retail (which can exceed $900 at some pharmacies), the savings are substantial.
Clinical Trials
Enrolling in a clinical trial is another way to receive semaglutide (the active ingredient in Ozempic) at no cost. Active trials are listed on ClinicalTrials.gov, where you can search by condition, drug name, and location. Trial participants receive the study medication for free and get regular medical monitoring throughout.
The trade-off is that trials come with strict eligibility requirements and time commitments. You may need a specific BMI, particular lab values, or a history of failed weight loss attempts. Some trials are placebo-controlled, meaning there’s a chance you’ll receive an inactive injection instead of the real drug. You’ll also need to attend scheduled visits, undergo blood draws, and follow study protocols for months or longer. Still, for people who meet the criteria and are comfortable with the process, it’s a legitimate path to free treatment.